Scientists track follicular Lymphoma's evolution in untreated patients
NCT ID NCT03190928
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 7 times
Summary
This study aims to collect blood, tissue, and bone marrow samples from 200 adults with untreated follicular lymphoma. Researchers will monitor participants every 4 to 6 months for up to 5 years to track how the cancer changes and responds to treatment. The goal is to better understand the disease's biology to help design future therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOLLICULAR LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Triple-Drug combo wipe out Slow-Growing lymphomas?
- Engineered immune cells take aim at Hard-to-Treat lymphomas
- Can a targeted pill boost Chemotherapy's punch against lymphoma?
- Can donor immune cells be engineered to fight blood cancer?
- Can a simple blood test spot lymphoma earlier?
- Can a targeted drug beat radiation for early-stage lymphoma?